Fluorescent glycofused tricyclic compounds were synthesized through the domino conjugate oxa-Michael addition/aldol condensation of 2-hydroxybenzaldehydes with protected 3-oxoglucal by exploiting activation with an organocatalyst. Stereoselectivity was obtained by using (R)-(+)-α,α-diphenyl-2-pyrrolidinemethanol trimethylsilyl ether as the catalyst. All synthesized compounds presented good optical properties. All compounds were able to bind to synthetic amyloid β 1-42 peptide aggregates and to label amyloid plaques from brain sections of transgenic mice affected with Alzheimer's disease with staining properties comparable to thioflavin T. We synthesize new fluorescent glycofused tricyclic compounds able to bind to synthetic amyloid β 1-42 peptide aggregates and to label amyloid plaques in brain-tissue samples from transgenic mice affected with Alzheimer's disease.
Synthesis and Preliminary Biological Evaluation of Fluorescent Glycofused Tricyclic Derivatives of Amyloid β-Peptide Ligands / G. D'Orazio, L. Colombo, M. Salmona, B. La Ferla. - In: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. - ISSN 1434-193X. - 2016:9(2016), pp. 1660-1664. [10.1002/ejoc.201501593]
Synthesis and Preliminary Biological Evaluation of Fluorescent Glycofused Tricyclic Derivatives of Amyloid β-Peptide Ligands
G. D'OrazioPrimo
;
2016
Abstract
Fluorescent glycofused tricyclic compounds were synthesized through the domino conjugate oxa-Michael addition/aldol condensation of 2-hydroxybenzaldehydes with protected 3-oxoglucal by exploiting activation with an organocatalyst. Stereoselectivity was obtained by using (R)-(+)-α,α-diphenyl-2-pyrrolidinemethanol trimethylsilyl ether as the catalyst. All synthesized compounds presented good optical properties. All compounds were able to bind to synthetic amyloid β 1-42 peptide aggregates and to label amyloid plaques from brain sections of transgenic mice affected with Alzheimer's disease with staining properties comparable to thioflavin T. We synthesize new fluorescent glycofused tricyclic compounds able to bind to synthetic amyloid β 1-42 peptide aggregates and to label amyloid plaques in brain-tissue samples from transgenic mice affected with Alzheimer's disease.File | Dimensione | Formato | |
---|---|---|---|
5_Synthesis and Preliminary Biological Evaluation of Fluorescent.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
771.24 kB
Formato
Adobe PDF
|
771.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.